There have been 1,024,400
fewer cancer deaths since
1990 and 1991 for men and
women, respectively, as
a result of declining death
rates ( 4).
is 27 Institutes and Centers;
funds 6,000 in-house
scientists and 50,000
external grants annually;
enables the work of more
than 432,000 extramural
researchers at more than
3,000 universities, medical
centers, teaching hospitals,
small businesses, and
research institutions; and
creates jobs in every state
and around the world.
Definitive Progress has Been Made Against Cancer
Significant progress has been and continues to be made against cancer. This progress is the result of
dedicated efforts across all sectors of the biomedical research enterprise to increasingly translate basic
scientific discoveries about cancer into new and better ways to prevent, detect, diagnose, and treat this
disease (see Figure 1, p. 3). Indeed, in just 11 of the 12 months since the AACR Cancer Progress Report
2012 (Sept. 1, 2012, to July 31, 2013), the U.S. Food and Drug Administration (FDA) approved 11 new
drugs for treating cancers, three new uses for previously approved anticancer drugs, and three new
imaging technologies (see Table 1, p. 4).
Due in part to advances like these, more people survive their cancers today than in the past (see Figure
2, p. 5). The National Cancer Institute (NCI) estimates that approximately 13. 7 million Americans with a
history of cancer were alive on Jan. 1, 2012 ( 1). This is almost 2 million more than its previous estimate
of nearly 12 million in 2008 (2), and more than 10 million more than in 1971, the year the U.S. Congress
passed the National Cancer Act ( 3).
The progress has been spurred by many decades of investments in basic, translational, and clinical
research by the federal government, philanthropic individuals and organizations, and the private sector.
Of particular importance are the investments in basic research supported by public funds through the
National Institutes of Health (NIH) and NCI. Together, investments in biomedical research from all sectors
have led to decreases in incidence for many of the more than 200 diseases we call cancer; cures for
some of these diseases; and higher quality and longer lives for many individuals whose cancers cannot
yet be prevented or cured.
In this section you will learn:
• There are an estimated 13. 7 million cancer survivors in the United States.
• More than 1. 6 million Americans are projected to receive a cancer diagnosis in
2013 and more than 580,350 are expected to die of the disease.
• Global cancer incidence is predicted to increase from 12. 8 million new cases
in 2008 to 22.2 million in 2030.
• Cancer is the most costly disease to our nation.
The Status of Cancer in 2013